Ticker League

Edwards Lifesciences (EW) Cash Flow Waterfall

Trace Edwards Lifesciences's operating cash flow down to free cash flow, then see where FCF goes — capex, buybacks, dividends, and debt repayment.

TTM

Operating CF

$1.36B

Capex

-$269M

Free Cash Flow

$1.09B

FCF Margin

+80.2%

Cash flow waterfall for Edwards Lifesciences (EW) — TTM through Q1 2026

Free cash flow: $1.09B

Note: Other Investing is large — driven mainly by purchases or sales of investments.

Cash flow breakdown for Edwards Lifesciences (EW) — TTM through Q1 2026

  • Operating Cash Flow$1.36B
  • Capital Expenditure-$269M
  • Free Cash Flow$1.09B
  • Acquisitions-$35.1M
  • Other Investing-$587M
  • Share Buybacks-$411M
  • Other Financing & FX-$758M
  • Net Cash Decrease-$701M
Want to see what drove the FCF change?Free Cash Flow Bridge

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation